跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 10 mL vial - TGA Drug Approval Details
Approvals
/
TGA
/
HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 10 mL vial
Approved
STANDARD
HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 10 mL vial
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
30be3e6489d3dc10
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
30be3e6489d3dc10
Product Name
HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 10 mL vial
Artg Id
207385
Artg Name
HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 10 mL vial
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2014-05-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/aa49f3646140819caba76b032b2b004a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a0a042b29b97fb74014f312f762160f3.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
30be3e6489d3dc10
Type
Standard
Back to TGA Approvals